Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2004, p. 1428-1433, Vol. 42, No. 4
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.4.1428-1433.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, Institute of Tropical Medicine, Antwerp,1 Department of Plant Systems Biology, University of Ghent, Ghent,2 Flanders Interuniversity Institute for Biotechnology (VIB), Zwijnaarde, Belgium,6 Projet RETRO-CI, Abidjan, Côte d'Ivoire,3 Medical Research Council Laboratories, Fajara, The Gambia,4 Department of Pathology, New York University School of Medicine, New York, New York5
Received 4 June 2003/ Returned for modification 25 September 2003/ Accepted 24 December 2003
We have developed and validated an oligonucleotide probe hybridization assay for human immunodeficiency virus type 1 (HIV-1) circulating recombinant form (CRF) CRF02_AG. In the p17 coding region of the gag gene, a CRF02_AG-specific signature pattern was observed. Five working probes were designed to discriminate CRF02_AG infections from infections by all other documented subtypes and CRFs in an enzyme-linked immunosorbent assay-based oligonucleotide probe hybridization assay. Nucleic acids were extracted from a panel of HIV-1-positive plasma samples from Cameroon, Bénin, Côte d'Ivoire, Kenya, Zambia, and Belgium and from blood spots from The Gambia. CRF02_AG (n = 147) and non-CRF02 (n = 100) samples were analyzed to evaluate and validate the oligonucleotide probe hybridization assay. The CRF02_AG-specific oligonucleotide probe hybridization assay has a high sensitivity and specificity, with good positive and negative predictive values in regions of high and low prevalence. A validation of the assay with West and West Central African samples indicated a sensitivity of 98.4% and a specificity of 96.7%. The oligonucleotide probe hybridization assay as a diagnostic tool will allow for rapid screening for CRF02_AG. This could be used to track the HIV epidemic in terms of documenting the real prevalence of CRF02_AG strains and will complement efforts in vaccine development. Moreover, this technology can easily be applied in laboratories in developing countries.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»